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ABSTRACT 
 
Background: Research misconduct is on the rise globally and it is jeopardizing scientific integrity by 
breaching the basis of responsible scientific conduct. Available data indicates rising levels of 
fabrication, falsification and plagiarism that are alarming despite the presence of guidelines in many 
of the high-income countries.  High profile cases of misconduct in low and middle income countries 
are on the rise as well, yet data regarding the amount of misconduct taking place remain scarce. 
Objective: To assess investigators’ attitudes as well as the prevalence of research misconduct in an 
Egyptian University and identify possible factors that might account for our results. 
Methods: We performed a cross-sectional survey study at the American University in Cairo (AUC) 
that included undergraduates, post-graduates and faculty. The survey tool included the following 
sections:  a) demographics, b) attitudes regarding the acceptability of certain practices in research 
conduct and c) frequency of observed and self-identified instances of scientific misconduct. The study 
was approved by the institutional review boards at AUC and at the  University of Maryland, 
Baltimore.  
Data Analysis: We used descriptive analysis  and a chi-square test for bivariate analysis.  We entered 
data by the use of SPSS software. A p value of 0.05 was considered significant  
Results:  We analyzed data from 191 participants 18 to 64 years of age. Of the respondents, 52.4% 
had received research ethics training.  
Regarding attitudes toward research misconduct:  
1) 77.3% expressed concern about the occurrence of research misconduct, 
2) 50.0% agreed that dishonesty and misrepresentation of data are common, 
3) 64.5% regard pressures to publish to gain promotion is a major reason for engaging in misconduct. 
4) 71.8% of participants confirmed their awareness of regulations that govern research involving 
humans, animals, or laboratory practices. 
Incidence of research misconduct observed at least once by participants included: plagiarism (43.8%), 
obtaining improper informed consents (34.6%), and eliminating data that contradicts one’s hypothesis 
(46.9%). Self-identified incidences for the same categories were 9.1%, 10.4%, and 26.0%; 
respectively. 
Conclusions:  The results indicate that misconduct is related to level of education, work environment 
in addition to possible ineffectiveness of training. Results may be explained by a lack of 
understanding or awareness of the unethical nature of research misconducts. This study provides 
insights on the attitudes towards and prevalence of misconduct among researchers in the Egypt.  
Limitations: This study included self-reporting of self-identified practices, which could represent an 
underestimate of actual practice.  Also, results from a single university may not be generalizable to 
other universities in Egypt and to other countries in the Middle East. 
Next steps: Data from other sites in Egypt and countries in the Middle-East are being gathered and 
will be pooled and analyzed with the data already collected. Further training in the responsible 
conduct of research is recommended. Further qualitative research (e.g., interview studies) is needed to 
further explore the reasons for our results. 
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INTRODUCTION 
Basis to Responsible Conduct 
 
Advancement in knowledge and science is based upon the contributions of new 
findings to the well-established knowledge. To maintain the integrity of science, 
systemic methods of documentation and circulation of science has evolved over the 
years.  
Today, academic publishing remains the main method of primary literature as 
recognized by the scientific community and acknowledged for references. New 
scientific concepts and methods have been introduced through methods such as peer 
review, scientific critique and citation. These processes of scientific contributions are 
well established, now aided by the advancement in communication through the internet 
has helped tracing back the origin of any work done. References and citations allow 
researchers to continue from where others have stopped.  
To confirm existing knowledge, previous work done by other researchers should be 
reliable, reproducible, and consistent. This can be achieved through the twelve 
principles of responsible research conduct defined by Shamoo and Resnik (Shamoo and 
Resnik, 2009). 
  
1. Honesty: in all aspects related to one's research reporting, including methods, 
contributions, conflict of interest and of course data that should be free from any 
misinterpretation, fabrication or falsification. This commitment does not only apply to 
publications but also to grant proposals, reports and other scientific communications.  
  
2. Objectivity: is required or expected in (but not limited to) the design of the 
experiments, the analysis and interpretation of data, writing of grant proposals, 
personnel decision, expert testimony and peer review. 
 
3. Openness: meaning being open to criticism and new ideas when sharing data, ideas, 
tools, results, resources and materials. 
 
4. Confidentiality: includes (but not limited to) protection of subjects private information, 
submissions of papers or grants, and business or military secrets.  
  
5. Carefulness: include keeping good records of all research activities to avoid error that 
are because of negligence, careful data collection, design of the research consenting of 
the participants are all important steps to increase competence in the scientific activity.  
 
 
6. Respect for colleagues: regardless of their ethnicity, background, religion, gender, and 
their qualifications. Meaning that this should extend to students and subordinates where 
training, mentoring and education should be exercised.  
 
7. Respect for intellectual properties: which includes abiding to copyright laws, 
honoring patents and similar forms of intellectual property protection laws; this also 
requires giving credit were appropriate and to avoid using unpublished data either 
results or methods without prior permission.  
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8. Respect for law: such as local laws and regulations, that may also extend to certain 
institution specific policies and regulations.  
 
9. Respect for research subjects: human subjects when part of research activities should 
be treated with respect meaning that the experiments they are involved in are very well 
designed to maximize benefits for them and to minimize harms or possible risks, human 
research subjects should never be treated as means to an end studies they are involved 
in should well preserve their privacy, autonomy and dignity. Additionally whenever a 
vulnerable population (such as children) is part of human subject research special 
measures and precautions should be in place to ensure their well being is not affected, 
and to ensure the burdens and benefits of the research are fairly distributed. Animal 
subjects as well should be treated with respect and are required to receive proper care as 
living beings; they should be saved from any poorly designed or unnecessary 
experiments.  
 
10. Stewardship: Utilizing human, financial and technological resources in the best way 
possible, by ensuring use of proper research sites, materials, samples and tools. 
 
11. Social responsibility: take into account the social consequences of research activities to 
prevent unfavorable consequences by seeking proper research, expert testimony, 
consulting and public education. 
 
12. Freedom: which should be granted by the governments and the research institutions, 
where freedom of thought and inquiry should be granted and not interfered with 
(Shamoo and Resnik, 2009). 
 
The History of Research Misconduct and its Regulation 
 
Over the past decades, increased evidence of lack of integrity in the scientific research 
process has created concerns over the reliability of available scientific literature and 
credibility of biomedical research (Nussenzveig and Zukanovich Funchal, 2008; Trikalinos et 
al, 2008; Jha, 2012). The lack of integrity in scientific work could be a consequence to many 
reasons, one of which is research misconduct, including fabrication, falsification and 
plagiarism in addition to other practices.  
 
Evidence of research misconduct is not a new trend.. As mentioned in the book 
Betrayers of the Truth, authors Broad and Wade discuss evidence of misconduct in work by 
famous scientists such as Galileo, Newton, Mendel, and Pasteur. With the increase in public 
knowledge and publicity of research misconduct, international bodies began to develop of 
guidelines and ethical codes of conduct such as the Nuremburg code (1948), Declaration of 
Helsinki (1964), the Good Laboratory Practices (GLP) in the early 1970s. During the 1980s, 
numerous cases of academic misconduct continued, with little abatement due to poor levels 
of resources and training from research institutions and inadequate treatment to the 
whistleblowers. These concerns triggered the establishment of the Office of Scientific 
Integrity (OSI) and the Office of Scientific Integrity Review (OSIR) in 1989 under the 
National Institute of Health (NIH) by the Department of Health and Human Services (DHHS) 
13 
 
in the United States. Today, these offices have been reorganized to be the Office of Research 
Integrity (ORI), which develops policies and promotes responsible scientific conduct. In 
addition, the office reviews and monitors investigations related to research misconduct and 
provides consultations to institutes for technical issues encountered in allegations of research 
misconduct (Shamoo and Resnik, 2009).  
 
Similar national bodies to the ORI have evolved in developed countries such as 
Denmark, Great Britain, Australia, Germany, Norway, Finland, Canada and Japan. Low- and 
middle- income countries are also seeing an increase in regulation for research, such as in 
Poland, China and India (Council of Science Editors, n.d.). One such example in the UK is 
the Committee On Publication Ethics (COPE). Established in 1997 by a group of medical 
journal editors, COPE now enlists over 9000 editors from different academic and scientific 
fields. COPE offers a code of conduct and guidelines for best practices to be adapted by 
member journals, guidelines from COPE are available on issues such as retractions and 
flowcharts on handling of ethical problems that are commonly encountered. (About COPE, 
n.d.). 
 
According to the US code of Federal Regulations Title 42 part 93, research 
misconduct is defined as “fabrication, falsification, or plagiarism in proposing, performing, or 
reviewing research, or in reporting research results." The federal regulations have specific 
definitions for each of these misconducts as follows: 
"(a) Fabrication is making up data or results and recording or reporting them. 
(b) Falsification is manipulating research materials, equipment, or processes, or changing 
or omitting data or results such that the research is not accurately represented in the 
research record. 
(c) Plagiarism is the appropriation of another person's ideas, processes, results, or words 
without giving appropriate credit. 
(d) Research misconduct does not include honest error or differences of opinion." 
(ECFR, n.d.) 
  
Moreover, research misconduct extends to other activities that we encounter in our 
daily lives and severely affects the scientific progress. Research misconduct is the failure to 
meet one or more of the twelve principles of responsible conduct and results in the negative 
impact the credibility of the scientific work. In addition to the misconducts defined by federal 
regulations for researches that involve human or animal subjects, namely falsification, 
fabrication and plagiarism, other issues concern authorship disputes, which are increasing, as 
well as conflicts of interest that affect the credibility and objectivity of researchers. All of 
these concerns will be discussed.  
A. Misconduct related to Research Ethics and Practices: 
Research involving human subjects:  
Human subject research is defined as per the code of federal regulations to be “…a living 
individual about whom an investigator (whether professional or student) conducting 
research obtains (1) Data through intervention or interaction with the individual, or (2) 
Identifiable private information.”  Over the years human research subjects were ill-
treated, abused and often extremely harmed due to participation in research activities that 
did not take into considerations their basic rights as human beings. Several scandalous 
cases in the last century have went high profile and received public attention that resulted 
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in development and advancement of the guidelines and regulations concerned with human 
subject research. The most notorious were the Nazi experiments in concentration camps 
during World War II, that conducted fatal inhumane tests on prisoners against their will, 
that lead to the ten commandments like memorandum referred to as the Nuremburg code, 
that was later on the basis to the Declaration of Helsinki, the corner stone of current 
regulations related to ethics of human research (Tyebkhan, 2003). 
Another major abuse in participant rights occurred with the Tuskegee syphilis 
experiment that took place in Tuskegee, Alabama. It lasted for 40 years during which 
poor African Americans were enrolled in a study that purposely left them untreated, even 
though during the course of the trial penicillin has proven to be an effective treatment to 
their condition, nobody received penicillin or any other treatment. The infamous study 
lead to congressional hearing that stopped the unjustifiable study after being featured in 
media. The study led to the development of the Belmont Report, the document regarded 
to be the moral framework upon which the US federal regulations related to human 
subject research can be understood.  
The Belmont Report, summarizes three main principles upon which all human subject 
research guidelines can be related namely Respect for person, Beneficence and Justice. 
Efforts to harmonize and standardize ethical standards related to conduct of clinical trials 
have been addressed in the International Conference of Harmonization under efficacy 6, 
Good Clinical Practice (GCP) which aims to ensure quality data that is consistent and 
applicable anywhere in the world combined with ethical conduct to safeguard 
participants. All the ethical codes and guidelines mentioned mandate that research 
involving human subjects to be: 
a. Scientifically sound based on solid results from preclinical experiments (in 
cases of clinical trials) and conducted by qualified individuals. 
b. Any foreseeable risks, should be minimized and justified by potential benefits, 
subjects safety and well being should prevail all other interests.  
c. Subjects’ privacy and confidentiality should be respected, and gathering of 
any personal information should be after obtaining their consent appropriately. 
Informed consent should be voluntarily, without any coercion or undue 
inducement, and subjects should always have the right to withdraw their 
consent without losing any benefits that they are entitled to otherwise.  
d. Studies should be ethically conducted, meaning that it should undergo ethics 
review by an ethics committee or an institutional review board. Where all the 
previously mentioned items are validated by an independent committee that 
also monitor the progress of the trial and intervenes when necessary. The 
committee as well ensures protection of vulnerable subjects such as minors, 
prisoners or mentally challenged individuals when they are research subjects. 
Research involving animals 
The guiding principles for the ethical use of animals in testing were set forth by Russel and 
Burch in 1959 by what is commonly known as The Three Rs (3Rs) principle. The first R 
refers to Replacement, referring to the preference of non-animal methods over using animals 
whenever possible, to achieve the same objective. The second R refers to Reduction, where 
the number of animals used to obtain the information should be as low as possible. The third 
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R refers to Refinement, where it is required to minimize potential pain or suffering by 
animals as much as possible (Russel and Burch, 1959). Shamoo and Resnik, add interesting 
fourth and fifth Rs, Relevance and Redundancy avoidance. These concepts can be 
summarized by ensuring that the context of using animals have medical, scientific or social 
basis, and that the suffering an animal can be exposed to is justified by the benefits to humans 
and the animals. Additionally, the experiments should not be repeated unnecessarily, this can 
be achieved by thorough research review to check if the experiment has been done before 
(Shamoo and Resnik, 2009). 
Local laws and institutional policies.  
Further laws and regulations can be applied more specifically to countries or states, 
sometimes institutions will have specific set of policies or regulations that is characteristic to 
the local values and social or political circumstances. These rules, regulations or policies will 
generally have more specific restrictions or further protective measures but it is quite unlikely 
that any local law would contradict the above mentioned ethical guidelines. Such laws may 
include (but are not limited to): 
a. Record keeping requirements and retention of documents. 
b. Documentation requirements. 
c. Rules for handling and disposal of materials such as bioactive materials, 
biohazardous waste, dangerous chemicals. 
d. Genetic, cloning and stem cell research regulations. 
 
B. Fabrication and Falsification in research  
While the definitions of fabrication and falsification in the CFR may appear clear, 
falsification or fabrication can nonetheless take place during analysis and interpretation of 
data. While a researcher may not completely make up from data from the scratch, he or she 
could manipulate the data, add a value to extrapolate results, drop outliers without disclosure, 
perform statistical analysis in a dishonest way, ignoring results that do not match the 
hypothesis and even enhance or modify images from the research (Shamoo and Resnik, 
2009).  
C. Plagiarism and Authorship disputes 
According to the Merriam Webster dictionary, the term plagiarism comes from 
plagiary of the Latin origin (plagiaries) which literally means “kidnapper”. Plagiarism is 
actually “kidnapping” ones words, ideas, and even expressions. Plagiarism definition is 
straight forward as per the code of federal regulation or any other definition in any guidelines 
or even a dictionary. However it remains as an ongoing issue among faculty, researchers and 
students. A study covering all PubMed accessible publications from 2008 to 2012 by Amos 
reveals the countries with the highest rates and largest numbers of retractions. China was the 
top reason for retraction due to either plagiarism or duplicate publications, Italy and Finland 
had the highest rates of plagiarism and the United States retracted the most publications 
(Amos, 2014). In 2008, Helen Zhang used CrossCheck text analysis software to detect 
plagiarism for the University of Zhejiang scientific journal in China, the results indicated that 
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31% of papers submitted over a period of 2 years were plagiarized the issue has been 
correlated to cultural aspects such as the tradition of quoting the exact masters word in 
Chinese tradition, a survey by the Chinese Association for Science and Technology showed 
that 31,000 researchers in China indicated that 43.4% regarded misconduct as a non-serious 
misconduct (Zhang, 2010). Yet this does not explain the reason for plagiarism in countries 
such as Italy and Finland. Other reasons include a lot of different aspects that in many times 
is more related to confusion or lack of understanding rather than intentional cheating 
(Bamford & Sergiou, 2005). Plagiarism is not necessarily copying word for a word that 
plagiarism detections software can detect, other forms of plagiarism includes plagiarizing 
ideas, self plagiarism that is a less severe form of plagiarism but results in double submission 
and possibility of copyright infringement (Shamoo and Resnik, 2009), or even rephrasing 
without citation, or citation without rephrasing. Academic Institutes like AUC have begun 
establishing strong policies to regulate plagiarism, mandatory trainings and practice using 
plagiarism detection software has helped students understand, avoid plagiarism and helped 
the faculty to detect plagiarized texts in assignments and manuscripts.    
Disputes over authorship can be considered to fall under plagiarism, however  
authorship concerns expand beyond denying citation when referring to someone’s words or 
ideas. It includes extreme cases such as denying authorship credit (or proper credit) to 
individuals who contributed substantively to a manuscript, or even giving authorship credit to 
individuals who had minimal or no contribution to a work as a form of mutual agreement. 
One example is to include the head of the department even if they practically did not 
contribute to the work done. The high competition among researchers to publish often causes 
disputes over authorship. Scholarly works are thought as important achievements for 
researchers to be promoted. Over the last decades the number of authors has increased 
surpassing the system of single author (Greene, 2007), especially in global collaborations and 
in huge research products and so did disputes over the extent of contributions and authorship. 
Authorship order is an important issue for discussion among collaborators, where 
traditionally the first author is the person who contributed most to the work and the last 
author is usually the principal investigator or the first author’s advisor. The remaining authors 
from second to second last are listed on the basis of who contributed the most. A different 
order takes place in other fields such as in mathematics, where they put author’s names in 
alphabetical order (American Mathematical Society, n.d.).  
Another common issue that is relatively new and on the rise is ghost authorship, 
where real contributors are not featured in authors list, this often occurs in industry and in 
clinical trials, where the protocol developers, statisticians and even manuscript writers are not 
featured, it is common to have medical writers or similar roles, reaching up to 91% in 
industry initiated trials (Gøtzsch, et al. 2007). 
D. Conflict of Interest 
Conflict of interest can be defined as a situation where an individual or institution are 
biased to make a decision because it possibly affects another advantage they posses, leading 
to a lack of objectivity. Individuals and institutions who work in scientific research are often 
challenged by their multiple duties, multiple duties can be hard to attain especially if some of 
these duties are in the way of other duties; thus creating a conflict of interest. For example, a 
person working as clinical research monitor working in a sponsored clinical trial is obliged to 
verify the eligibility of the subjects participating in the trial to ensure they strictly match the 
inclusion and exclusion criteria. This task involves disenrollment of subjects who are 
ineligible. However, the same clinical research monitor often has a target set by the 
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sponsoring company to enroll a certain number of subjects upon which he gets his appraisal. 
Such set up makes the monitor have multiple conflicting objectives, in this situation to verify 
enrolled subjects for eligibility is not consistent with recruiting patients, because monitors in 
fact do not recruit patients, they just verify they are eligible to participate.  
Clinical investigators working in similar sponsored trials are often paid a sum of 
money for each participating subject; the investigators will earn more money if they recruit 
more patients, the same investigators are often the ones who consent the patient and explain 
to them the risks of participation and talk them into accepting to participate.  
Another area where conflict of interest may arise is with the intuitional review board. 
The IRB that reviews and grants approval to conduct the study may consist of colleagues and 
friends to the clinical investigator. The same institution that offers a clinical investigation site 
for the sponsoring company earlier on received a donation directed towards developing of the 
department that the clinical trial is conducted in, the same institution should be responsible in 
the investigation of any reported misconduct or handle complaints. While the above examples 
are hypothetical, they are inspired by realistic scenarios of observed current clinical research 
concerns. As the examples show, the conflicts of interest could be financial, ethical, social, 
personal and even political in addition to being complexly interlinked. 
As science is becoming more associated with business, and as the competition grows 
bigger, the conflicts of interest may not be avoided.  Therefore, conflicts of interest need to 
be declared to the ethical committees during review of the potential studies. While 
nondisclosure is misconduct itself, it can also be tied to other forms including but not limited 
to: fabrication and falsification to maintain a grant, to graduate, to start a spinoff company, 
authorship misconduct and disputes to get promoted, compromising scientific rigor of the 
design of studies or ignoring certain results to match your hypothesis,  not respecting research 
ethics or not follow proper research practices to cut corners and to attain specific objectives 
while ignoring ethical duties.  
Regulations determine how an investigator discloses a conflict of interest. For 
example, many peer-reviewed journals require statements from the authors declaring any 
potential conflicting interests they would have. The Code of Federal Regulation also requires 
principal investigators and sub-investigators to declare any financial conflict of interest on 
financial disclosure form for themselves or any of their dependents.  
 
Prevalence of Research Misconduct 
  
The available data regarding research misconduct is mostly associated with developed 
countries. This association may be due to available means of identifying such practices and a 
relatively higher level of transparencies from governments and institutions. Currently there is 
growing mass of collaborative work in the Middle East region, along with a general increase 
in the amount of research activities occurring in the region. Hence, data must be gathered to 
know how reliable is the structures of research integrity and responsible conduct are for 
producing scholarly, evidence-based research. Due to the lack of oversight of research 
integrity, current available data is scarce; therefore more research is needed in this realm.  
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 In a study by Fanelli, who conducted meta-analysis and systematic review of 
quantitative survey data addressed to scientists, provided data that resulted with up to 14% of 
scientists in higher income countries have been observed to engage in falsification or 
fabrication and up to 75% have been involved in other practices that are questionable 
(Fanelli, 2009). 
 
Data available from high income countries may also have limitations due to its 
reliability .Data from  low and middle income countries are not available, yet many high 
profile cases of research misconduct have occurred in low and middle income countries. 
These cases, which received ethics approval, include a fraudulent clinical trial involving high 
doses of chemotherapy in South Africa, a study involving patients with liver cancer, and 
dozens of retracted publications from India (Ana, 2013).  
 
Another example from a survey study conducted in India between August 2012 and 
March 2013 targeting medical researchers who had a minimum of five publications in several 
institutes showed that 53% of respondents had observed plagiarism, 33.5% of responders 
observed denial of authorship to individuals who had contributed significantly to the 
research, and 65% observed gift authorship (Dhingra and Mishra, 2014).            Two studies 
from the Middle East (Kandeel et al. and El-Dessouky et al) assessed awareness and attitudes 
of Egyptian faculty about research ethics.. Both papers showed a positive attitude (reaching 
up to 90%) towards research ethics committees, but research ethics practices were 
suboptimal.  For example, more than 35% of participants indicated that it is not necessary to 
provide patients with research details since they do not understand it (Kandeel et al.); 11.2% 
of responders found it acceptable to fabricate data to improve quality of the research as long 
as the patient is not harmed and 39.2% thought that vulnerable subjects such as the mentally 
challenged or children can provide consents for themselves. 32.8% thought informed consent 
was not necessary for obtaining blood tests for a clinical study (El-Dessouky et al., 2011). 
 
Possible Reasons for Research Misconduct:  
 
Lack of training: Results from work done in the Middle East indicate gaps in training on 
research ethics, faculty members perceived ethics committees as reasons for delay in their 
research (Kandeel et al., 2011; El-Dessouky et. Al 2011).  Moreover, data also suggest that 
only 20% of chairpersons of ethics committees and 25% of members of ethics committees in 
Eastern Mediterranean region received training in research ethics (Abou-Zeid A, Afzal M, & 
Silverman HJ, 2009). 
  
Pressure to publish: "publish or perish" is a policy that significantly affect the pressure for 
misconduct (Casadevall and Fang, 2012), in almost all universities and institution the 
academic value of faculty members is based on how much they publish, where do they 
publish and how often their publications are cited. This defines promotions, grants, and 
prestige.  
   
Ease of fabrication (Shamoo and Resnik, 2009): as in doing research backwards, starting 
with a hypothesis and creating data to support or modifying the available data to support it is 
a shortcut to obtain significance and publish. 
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Not reporting conflict of interest: Conflict of interest by itself may not be considered 
misconduct, but the presence of conflicts of interest or too much tempting conflicts could be a 
strong motive to do other misconducts. Therefore not reporting conflict of interest is 
misconduct.       
 
Lack of oversight and regulation: The lack of respect to the public, to research and the 
possibility of getting away with misconduct promote misconduct especially with corrupt 
regimes.  
 
Culture and Environment: A culture that accepts cheating, could possibly create a negative 
pressure towards doing things ethically, as in individuals who wish to stick to ethical 
standards can never be taking equal or fair chances in an environment that is not ethical, if 
they will not engage in unethical practices it is likely that they will become at least neutral to 
it. 
  
Effect and Consequences of Misconduct: 
  
Losing Public trust: As mentioned earlier, most of the regulations were developed in 
response to scandals that went high profile, such as the Tuskegee experiment that was 
stopped by a congressional hearing after being featured in media, meaning that results after 
all affects the public and the scientific community cannot afford losing public trust when they 
eventually react to what affects them. For example a recent law suit is filed against Egyptian 
army officials for claiming to have invented a device that can completely “cure” patients 
infected with HIV and Hepatitis virus C raising hopes  of millions of patients over 
exaggerated media propaganda that had no scientific basis whatsoever (El-Fekki, 2015). 
 
Placing research subjects at risk: misconduct can result in patients receiving improper 
medical care based on fraudulent research or based on results of other fraudulent research. 
According to Steen the numbers of those patients are in hundreds of thousands, participating 
in multicentre clinical trials (Steen, 2011).  
 
Wasting Resources: In addition to possible harm or lack of benefit to research participants, 
research misconduct leads to a waste of resources, including time, money and effort and 
could create confusion when trying to replicate results or base new advancement on older 
ones.  
 
Retraction: In a study by Fang, examination of 291 retracted articles funded by NIH between 
1992 and 2012 showed that about 96% of them were retracted due to either falsification or 
fabrication, the remainder of the retractions were due to other serious misconducts such as 
conducting research without IRB approval.  An estimated total of 1.67 billion USD (corrected 
to 2.32 billion USD in 2012 in consideration to inflation) of funding by NIH for papers that 
were later retracted for misconduct.  
   
Other costs: Along with negative reputation and possibility of legal and civil liability, 
misconduct investigations can cost up to 500,000 USD for a single case, which could 
possibly be more than the amount of money spend on the research itself (Stern et al, 2014). In 
addition, the duration of investigations of the misconduct can take upwards of 10 months 
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from allegation to final action by an institution in the United States, without taking into 
consideration further appeals or deliberations by ORI (Shamoo and Resnik 2009).  
 
 
 
 
The Study 
A knowledge gap exists regarding attitudes of an prevalence of practices regarding 
research misconduct in the Middle East.  Additionally, factors that can account for 
certain attitudes and practices need to be studied. Accordingly this study aims to:   
a. Determine the prevalence of attitudes and practices regarding research misconduct in 
Egypt. 
b. Determine the independent factors that might account for these attitudes and prevalence 
regarding research misconduct. 
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METHODS 
Survey Tool 
We adapted a survey tool from the Scientific Misconduct Questionnaire-Revised 
(SMQ-R) that was developed by Broom et al.. This tool is comprised of qualitative and 
quantitative questions designed to examine misconduct through seven domains: 
demographics, characteristics of the work place, work place environment perception, 
scientific misconduct prevalence, awareness about scientific misconduct and reporting it, 
attitudes and beliefs about misconduct, experiences with scientific misconduct and behavioral 
influences affecting it. The SMQ-R addressed research coordinators who enrolled and 
followed research subjects (Broom et al., 2013). 
Our adapted survey tool (Appendix I) consists of the following 6 sections: 
I- Demographic Information: composed of ten questions to identify age, gender, nationality, 
highest degree achieved, location of graduate school, current academic position, previous 
scientific research experience, types of research activities and previous training in research 
ethics and research misconduct. 
II- Prevalence of Scientific Misconduct: Divided into two sections; one set of questions asked 
the participants about their observations of misconducts among their colleagues while the 
other set of same questions asked the participants to self report their engagement in any of 
these practices. Each set of questions addressed six topics (two to four questions) in each of 
the following areas of misconduct: Research Ethics, Data Fabrication and Falsification, 
Plagiarism, Authorship, Conflict of Interest, and Research Practices. The responders were 
given the opportunity to reply for each question by either "Never", "Once or twice" or "Three 
or more".  
III-Acceptability of Practices in Conduct of Research: Participants were asked general 
questions related to their perceptions regarding unethical practices in the areas of Research 
Ethics, Data Fabrication and Falsification, Plagiarism, Authorship and Conflict of interest. 
This section used a Likert-scale method to gauge participants’ agreements regarding the 
acceptability of misconduct. The scale had five degrees of acceptability (Very Acceptable, 
Acceptable, Neutral, Unacceptable, and Definitely Unacceptable). 
IV- Attitudes of Scientific Misconduct: A set of nine questions asking participants how much 
do they agree with the following: concerns about amount of misconduct, responsibility of 
misconduct lies with principal investigators only, commonality of dishonesty and 
misinterpretation of data, necessity of reporting instances of research misconduct, availability 
of appropriate mechanisms to report misconduct, pressure to publish is a reason for engaging 
in misconduct, necessity of declaring conflict of interest by investigators, monitoring trainees 
to ensure developing into responsible researchers, and awareness of regulations related to 
humans, animals and laboratory practices. Responders had the opportunity to strongly agree, 
agree, be neutral, disagree, or strongly disagree with each of these statements.  
V- Questions about Scientific Misconduct: This part is comprised of five hypothetical cases 
involving misconducts related to conflicts of interest, plagiarism, fabrication, falsification, 
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and authorship. The responders were asked question about the proper course of action and 
were given four choices to choose from.   
VI- Assessment of the Survey: This part was to assess how responders see the survey, how 
long did they need to complete it, what parts they thought were not important, other areas not 
addressed and if they had further comments.  
Target Population  
We targeted  individuals involved in scientific research activities at the AUC.  These included: 
undergraduate students, MSc students, PhD students, and individuals working in research positions 
(e.g. research assistants) and working in teaching academic positions that may also involve research 
activities (e.g. faculty)  
Recruitment Methods  
The recruitment method was based on convenience sampling technique.  We 
distributed the survey via a web link on SurveyMonkey® and the link to the survey was 
distributed via a recruitment email (Appendix II). The email was sent to all graduate students 
and to members of the schools of sciences and engineering that included faculty, staff and 
students. Additionally, colleagues were verbally invited to complete the questionnaire and 
were encouraged to invite others who are eligible to complete it by word of mouth. An 
opportunity to enter a raffle to win an iPad mini, was used as an incentive to enhance 
recruitment efforts.  
Ethical Considerations 
Confidentiality: Due to the sensitivity of linking disclosed data to respondents, we collected 
all data anonymously. No names or other identifiers were requested from participants to be 
included in the survey. Those participants who entered the raffle sent separate emails with 
their names which can never be linked to their survey answers in SurveyMonkey. The 
participants were informed that their data will only be presented in aggregates and will never 
be used to identify or report individuals.  
Informed Consent:  Participants gave their informed consent as indicated when they clicked 
on the continue button after they read the first page of the survey (Appendix I)  that included 
the necessary elements of informed consent.  
Ethics Review: The study was exempted from the IRB of the University of Maryland, 
Baltimore (Appendix IV). It was reviewed and approved by the AUC-IRB (Appendix III), the 
AUC-IRB has reviewed the consent form, the recruitment email and methods and all 
suggested recommendations from the IRB side were implemented. 
Sample Size Determination 
An estimated population size of about 400 participants were identified with these 
criteria at AUC, the sample size calculation based on a confidence interval of 5 and a 
confidence level of 95% is 196 participants. 
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Data Analysis 
The data extracted from SurveyMonkey were entered into SPSS statistical software.  
We used descriptive analysis and chi-square analysis to assess correlations between responses 
and independent factors that included gender, level of education, and presence of prior ethics 
training. A p-value of 0.05 or less was considered significant. Charts and graphs were 
constructed using SPSS or Microsoft Excel.   
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RESULTS 
Demography and Background: 
 
Figure 1:Positions held by participants 
  
 
 We obtained data from 191 participants from the American University in Cairo (AUC), 
95 of whom completed the entire survey. Participants represented students, faculty and staff  
from the Schools of Sciences and Engineering. .  Ages ranged from 18 to 64 years (mean of 
28.2 years (SD ± 7.88 years and median of 27.0 years) with about 140 participants (73.3%) 
falling between 20 and 30 years of age 
 
Table 1 shows that two thirds of participants were females, the majority were Egyptian 
(91%).  More than 80% were students at different levels. 52.4% received ethics training, 
however 56% of which indicated that the training addressed research misconduct. 
 
.  
Research Experience: 
  
Regarding participation in scientific research, about 60 % indicated previous 
experience in research.  Only the answers of those who participated in scientific research 
were considered in analysis of the questions related to prevalence of misconduct as per one's 
self experience (Section III of results), responders answers - whether or not participated in 
research before - about prevalence based on observations of colleagues and their attitudes 
were still considered. Those who did not participate in research before were mostly 
undergraduates or graduate student who has probably not started working in research yet 
including their thesis (p < 0.001). 
 
Figure 2 shows about half of the participants who worked in research were involved 
in laboratory research (49%) , specifications in "other" category (21.9%) included (but was 
not   limited to), architecture, bacterial samples, bioinformatics, cell lines, engineering, 
ergonomics,  software simulation and research using plants.  
 
 
 
 
Undergraduate 
student, 
18.80% 
MSc student, 
34.00% 
PhD Student, 
12.60% 
Research 
Position, 8.40% 
Academic 
position, 9.40% 
Others, 16.80% 
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 Figure 2: Types of research participants were involved in(y axis: Research Type, x axis: percentage) 
 
 
Unethical Practices Prevalence and Acceptability: 
 
Table 2 shows the response rate for different groups of questions and their percentages, 
the responses for different categories of research misconduct were as follows:  
 
 
1. Research Ethics:  
Table 3 shows the participants’ responses regarding their views about several issues in 
research ethics.  
 
Table 3 shows the out of the 112 participants (58.6%) who answered these questions, 
10.7% of them believed it is very acceptable or acceptable to conduct research involving 
human subjects without IRB/EC approval and another 8.9% were neutral about the issue. In 
regards to use of confidential information without authorization from research participants, 
the degree of acceptability of use of confidential data without authorization (7.1%) and not 
obtaining proper informed consent (6.3%) were close, whereas twice as much of those who 
were neutral in regards to the use of confidential data without authorization (5.4%), were 
neutral about not obtaining informed consent (10.4%). 
 
Table 4 shows approximately 15.4% of the responders observed one or two occurrences 
of research involving human subjects being conducted without prior IRB approval, and three 
or more times by 6.2% of the responders. Only 7.8% of the responders self reported as “once 
or twice” and three or more times by 2.6%. Use of confidential information about research 
49% 
23.7% 
21.9% 
12.2% 
21.9% 
0 10 20 30 40 50 60 
laboratory research 
human subject research  
experimental animals  
human biological samples 
other 
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subjects without their authorization was observed once or twice by 15.4% of the responders, 
and by 4.6% of the responders, three or more times, while it was self reported as “once or 
twice” by 6.5% of the responders, nobody self reported use of confidential information 
without authorization more than two times. Not obtaining proper informed consent from 
participants was observed once or twice by 22.3% of the responders, and by 12.3% of the 
responders, three or more times, while it was self reported as “once or twice” by 7.8% of the 
responders, and three or more times by 2.6%.  
  
 
2. Falsification and Fabrication: 
 
The following set of questions were related to fabrication and falsification of research data, 
table 5 shows that making up of research data was indicated to be highly acceptable or 
acceptable by about 9.8% of the responders, however less than 2 % were neutral to making 
up of research data. Changing research data without mentioning it was indicated to be 
acceptable or very acceptable by 5.4 % and another 5.4% were neutral to it. Dropping outliers 
without mentioning it in particular was indicated as very acceptable or acceptable by 7.1% 
and 9.8% had a neutral opinion about it. Selection of data only that supports one's hypothesis 
was very acceptable or acceptable by 8.9% and 19.6% were neutral to this. 
 
 Table 6 compares observations and self reporting of misconducts, where it is shows higher 
rates of observation of misconduct than self reporting. Where no self reporting of more than 2 
times recorded except for “selecting only those data that support your hypothesis” 
 
 
 
3. Plagiarism  
Another set of questions introduced to participants were related to plagiarism, Table 7 
shows that 4.5% of responders indicated that it is very acceptable to publish results that 
belong to someone else, no body found this only acceptable or was neutral about it though. 
Using others words or ideas was indicated to be very acceptable or acceptable by 5.4%, and 
no body as well was neutral in this regard. 6.3% of the responders to this set of questions 
indicated that multiple submissions were very acceptable or acceptable, and another 5.4% 
were neutral about double submissions.  
 
Table 8 shows that 43.8 % of responders observed plagiarism while about 9.1% self 
reported plagiarism. The trend also shows that observation or self reporting or “once or 
twice” is always higher than “three or more times”   
  
 
4. Authorship 
The next set of questions addressed ethical issues related to authorship, 8% of the 
responders indicated that is very acceptable or acceptable to give authorship credit to 
someone who has not substantively contributed to a manuscript. On the other hand 4.5% 
found it very acceptable to deny authorship credit to someone who substantively contributed 
to a manuscript. And 7.1% found it either very acceptable or acceptable to have their names 
put as a contributor on a paper they have not made reasonable contribution to. The responders 
who were neutral to giving false authorship credit, denying authorship credit and being 
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mentioned as one of the authors without a significant contributor were 4.5%, 0.9% and 4.5% 
respectively as summarized in Table 9 
 
Table 10 shows that giving authorship credit to someone who has not contributed 
substantively to a manuscript was observed at least once by 37% of the responders, and while 
it was self reported at least once by about 15%. Denying authorship credit to someone who 
has contributed substantively to a manuscript was observed at least once by 25% of the 
responders, and by and it was self reported by about 5% of the responders.. 
 
 
5. Conflict of interest 
 
About 4.5%of responders indicated that not disclosing conflict of interest (like financial 
interest with a drug company) to the journal or ethics committee is very acceptable or 
acceptable. 3.6% found it very acceptable or acceptable to compromise the rigor of the study 
design or methodology or to inappropriately alter or suppress the results in response to 
pressure. 8% were neutral towards all three aspects namely not disclosing such conflicts of 
interest, compromising the rigor of study design or methodology and suppressing research 
results in response to pressure as summarized in Table 11, 
Table 12 comparing the rates of observed and self reported misconducts indicate that 
about 13% of the responders were aware of a conflict of interest that was not disclosed to 
either the ethics committee or a journal at least once, while it was self reported as “once or 
twice” by 5.2% of the responders.  Compromising the rigor of a study's design or 
methodology in response to pressure from a commercial or not-for-profit funding source was 
observed once or twice by 11.5% of the responders, and by 1.5% of the responders, three or 
more times, while it was self reported as “once or twice” by 3.9% of the responders, and none 
self reported more than once or twice. Inappropriately altering or suppressing research results 
in response to pressure froma commercial or not-for-profit funding source was observed once 
or twice by 10.0% of the responders, and by 0.8% of the responders, three or more times, 
while it was self reported as “once or twice” by 3.9% of the responders, and none self 
reported more than once or twice.  
 
 
  
6- Prevalence of misconduct in other Research Practices 
 
Looking at misconducts related to Research Practices, Table 13 summarized rates of 
misconducts observed and self reported for Ignoring aspects of animal-subjects research 
requirements, material handling and providing inappropriate recommendation letters. It was 
observed at least once by 17,7%, 34.6% and 23% of the responders respectively while it was 
self reported by responders at least once by 9.1%, 27.3% and 6.5% respectively.  
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Attitudes towards misconduct and responsibilities 
  
A- Similarly, nine statements were presented to participants, and respondents had to choose 
between strongly agree, agree, neutral, disagree or strongly disagree for each statement.  
110 participants responded representing 57.6 % of all participants. Results summarized in 
Table 14. 
 
  
B- Additionally, the 5 case studies were presented and participants were asked to choose the 
best answer from multiple choice pre-defined answers, the questions and the answers of 
respondents were as follows: 
  
 
In case 1: 49.7% of participants responded to this question (95 responders), 71.6% of which, 
answered correctly by choosing answer C. (Table 15) 
 
In case 2: 49.7% of participants responded to this question (95 responders), 51.6% of them 
chose not to go with the company proposal, while 41.6% see that the company proposal is 
acceptable as long as the ethics committee is notified.(Table 16) 
 
In Case 3: 49.7% of participants responded to this question (95 responders), 74.7% of 
responders chose to talk to Dr. Ahmed while 16.8% chose to report him to the ethics 
committee. A minority chose to remain silent (3.2%).(Table 17) 
  
In Case 4: 49.7% of participants responded to this question (95 responders), 82.1% of which 
chose to report the findings as such, the remaining 17.9% chose answers that are considered 
either falsification or fabrication or both. (Table 18) 
 
In Case 5: 49.7% of participants responded to this question (95 responders), 76.8% of which 
chose to withdraw the paper, a 13.7% thought it is sufficient to apologize to the author of the 
other paper. (Table 19) 
 
Correlation Data 
 
I. Correlation between Degree Earned and Acceptability of 
Research Ethics Practices.  
Figure 3 shows participants’ acceptability of misconduct in different categories correlated 
to degree earned. The correlations show that at least 50% of those who found unethical 
practices acceptable had BSc or BA as their highest degree of education, reaching up to 
81.9% in fabrication for example. The percentages of acceptability of unethical practices 
generally becomes less as the highest degree becomes higher this was statistically 
significant for Q1, the percentage of MSc or MPH holders who find unethical practices 
acceptable is consistently less with the exception of conflict of interest questions, it is also 
notable that the overall number of those who found conflict of interest acceptable is only 
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4 participants PhD holders generally did not find any of these misconducts acceptable, 
with the exception of a single person in each of the questions related to use of confidential 
information without authorization, not obtaining proper informed consent, dropping 
outliers without mentioning it and selecting data that only support their hypothesis. 
(Figure 3 
 
 
Figure 3:  Correlation between Degree Earned and Acceptability of Research Ethics Practices  
(n= 112  ) 
 
Key: 
*p<0.05  
Q1: Conducting research involving human subjects without prior approval from an Institutional Review Board or Ethics Committee 
Q2: Use of confidential information about research subjects without their authorisation 
Q3: Not obtaining proper informed consent from participants 
Q4: Making up research data 
Q5: Changing research data without mentioning it. 
Q6: Dropping “outliers” without mentioning it 
Q7: Selecting only those data that support your hypothesis 
Q8: Publishing results that belong to someone else 
Q9: Using someone else’s words or ideas without giving proper credit 
Q10: Submitting a manuscript to a journal that you already published in another Journal 
Q11: Giving authorship credit to someone who has not contributed substantively to a manuscript 
Q12: Denying authorship credit to someone who has contributed substantively to a manuscript 
Q13: Allowing your name to be put on papers to which you have made no reasonable contribution to 
Q14: Aware of a conflict of interest (e.g. you have a financial interest with a drug company and you are conducting a study for them) and did not 
disclose it to either the ethics committee or a journal 
Q15: Compromising the rigor of a study's design or methodology in response to pressure from a commercial or not-for-profit funding source 
Q16: Inappropriately altering or suppressing research results in response to pressure from a commercial or not-for-profit funding source 
 
II. Correlation to Experience in research: 
Figure 4 shows participants’ acceptability of misconduct in different categories correlated to 
their previous experience in scientific research.  
 
 
Figure 4:  Correlation between prior Research Experience and Acceptability of Research Ethics 
Practices  
(n= 112  ) 
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Key:  
*p<0.05 
Q1: Conducting research involving human subjects without prior approval from an Institutional Review Board or Ethics Committee 
Q2: Use of confidential information about research subjects without their authorisation 
Q3: Not obtaining proper informed consent from participants 
Q4: Making up research data 
Q5: Changing research data without mentioning it. 
Q6: Dropping “outliers” without mentioning it 
Q7: Selecting only those data that support your hypothesis 
Q8: Publishing results that belong to someone else 
Q9: Using someone else’s words or ideas without giving proper credit 
Q10: Submitting a manuscript to a journal that you already published in another Journal 
Q11: Giving authorship credit to someone who has not contributed substantively to a manuscript 
Q12: Denying authorship credit to someone who has contributed substantively to a manuscript 
Q13: Allowing your name to be put on papers to which you have made no reasonable contribution to 
Q14: Aware of a conflict of interest (e.g. you have a financial interest with a drug company and you are conducting a study for them) and did not 
disclose it to either the ethics committee or a journal 
Q15: Compromising the rigor of a study's design or methodology in response to pressure from a commercial or not-for-profit funding source 
Q16: Inappropriately altering or suppressing research results in response to pressure from a commercial or not-for-profit funding source 
 
III. Correlation to prior ethics training: 
Data for participants who found any of the questions about misconduct in different categories 
acceptable or unacceptable were extracted and correlated to their previous training .(Figure 
5).  
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Figure 5:  Correlation between prior Training on Research Ethics and Acceptability of Research 
Ethics Practices (n= 112  ) 
 
 
Key:  
Q1: Conducting research involving human subjects without prior approval from an Institutional Review Board or Ethics Committee 
Q2: Use of confidential information about research subjects without their authorisation 
Q3: Not obtaining proper informed consent from participants 
Q4: Making up research data 
Q5: Changing research data without mentioning it. 
Q6: Dropping “outliers” without mentioning it 
Q7: Selecting only those data that support your hypothesis 
Q8: Publishing results that belong to someone else 
Q9: Using someone else’s words or ideas without giving proper credit 
Q10: Submitting a manuscript to a journal that you already published in another Journal 
Q11: Giving authorship credit to someone who has not contributed substantively to a manuscript 
Q12: Denying authorship credit to someone who has contributed substantively to a manuscript 
Q13: Allowing your name to be put on papers to which you have made no reasonable contribution to 
Q14: Aware of a conflict of interest (e.g. you have a financial interest with a drug company and you are conducting a study for them) and did not 
disclose it to either the ethics committee or a journal 
Q15: Compromising the rigor of a study's design or methodology in response to pressure from a commercial or not-for-profit funding source 
Q16: Inappropriately altering or suppressing research results in response to pressure from a commercial or not-for-profit funding source 
 
IV. Correlation with Gender: 
Self reporting among males and females and acceptance of unethical behavior among 
males and females was cross tabulated against all questions to identify percentages 
differences between both genders. Comparing percentages among males and females in 
regard to self reporting shown in Table 20, and percentages of males showing acceptance to 
unethical behavior, are shown in Table 21.  
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DISCUSSION 
 
 
Self reported and Observed practices 
Evidence of intentional misconduct is difficult to identify, however, there is no better 
evidence than self-reporting of the person who committed the misconduct, even though it is 
unlikely though that a person who would commit misconduct will admit it, the survey still 
yielded responses in self reporting. The presence of questions related to acceptability of these 
misconducts, previous training and awareness of regulations helped to understand whether 
engaging in misconduct is intentional, or is it unawareness or peer or environment pressure.  
 
The case studies presented to the participants, reflect a general tendency of the 
majority to do what is ethical or likely ethical from their perceptions in a real situation, the 
choices being close ended did not give the participants a chance to elaborate why this 
particular action was particularly chosen yet some responses even though not correct reflect a 
sense of decency or respect of the participants to the research set up, for example in case 2, 
51.6% of participants would turn down the offer from the pharmaceutical company, possibly 
because it sounds fishy or because it is a conflict of influence that can imposes a strong 
influence on the investigator, this might also indicate that the responders may not be aware of 
that under some conditions it is acceptable to have some conflict of interest but it is important 
to be declared. Only 2.1% went with accepting the proposal and not disclosing conflict of 
interest. Another example is in Case #5 where the majority of the responders chose to 
withdraw the paper, while the second most common answer was to apologize to the author, it 
is not the correct answer, but it reflects that responders are aware that this is something wrong 
and willing to correct it, but maybe they are not aware of the most proper corrective action to 
take. Nevertheless, the remaining wrong choices reflect a tendency engage in falsification, 
fabrication and plagiarism.  
Prevalence of misconduct in regards to falsification and fabrication as per self 
reporting (ranged between 9.1% and 26% in different questions as shown in table 6). This is 
much higher as compared to the rates of self reporting in response to direct questions 
regarding altering data in the study of Fanneli which was only 0.3% to 4.9%. Similarly for 
observed misconduct the rate of reported observation lied between 5.2% and 33.3% as 
compared to 30.8% and 46.9% in our survey (Fanelli, 2009).  This is not conclusive because 
the population demographics are different and the questions asked were phrased differently.  
 In regards to the prevalence based on observation of other colleagues the results 
suggest that misconduct is generally observed at a higher rate than self reported misconduct. 
This is consistent with the earlier indication that self reporting could always be an 
underestimate. The results summarized in Table 14 show that 77% of the responders 
indicated that the amount of misconduct that occurs is concerning, 50% of the responders 
believe that dishonesty or misrepresentation are common, and another 25.5% are neutral in 
this regard. 72% of the responders indicated that they are aware of the regulation that govern 
research involving humans, animals or laboratory practices,  and  66.4% also believe that the 
responsibility of the misconduct does not only lie with the principal investigator. About 64% 
of the responders believe that the pressure to publish studies to gain promotion is a major 
reason for engaging in misconduct. About 85% of the responders agree or strongly agree that 
investigators need to declare conflict of interest and those investigators should report 
instances of research misconduct, however, 66% monitor their trainees to develop responsible 
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researchers and about 50% agree that the mechanisms to report the misconduct are 
appropriate 
 
Correlation Analysis 
 
Kisamore et al. have identified in their study that “integrity culture” was the most 
influential factor to variance academic misconducts such as cheating (Kisamore, 2007). It 
was also noticeable that observations were consistently higher with higher self reporting in an 
indication that a causal relationship might exist between observation of misconduct and 
tolerating or engaging in it.  
Taking a deeper look at the results of questions in every area of misconduct showed 
that a number of participants ranging from 3.6% to 10.7% find such misconducts acceptable 
or very acceptable.  
Accordingly several correlation factors were studied to assess the possible factors that could 
contribute to such acceptance of misconduct and to engagement misconduct.  
 
Highest degree obtained in relation to acceptance of misconduct: The survey results 
suggest that acceptability of misconduct becomes less among responders who hold higher 
level degrees, the comparison in Figure 3, between BA/BSc degrees, MSc. degrees, and PhD  
holders ,  indicate that PhD holders were less accepting to unethical behavior than MSc. 
holders.  Similarly Msc. holders were less accepting to unethical behavior than BSc. Holders. 
This could possibly be explained based on the fact that PhD programs and most of the MSc. 
programs would include research work such as thesis as part of their requirements to obtain 
the degree, which is not the case with BSc. where only some programs require this.  
 
Research experience effect on acceptance of misconduct: Another correlation to research 
experience was studied to confirm this, but it was not conclusive as the individuals identified 
as accepting research misconduct were almost equally distributed between those who had 
research experience and those who had not. This correlation could not confirm if the 
experience of the participants had an effect on their views acceptance of unethical practices, 
the percentages of participants who find unethical practices acceptable or very acceptable 
were equally distributed among those who previously conducted research or those who have 
not previously conducted research, it was statistically significant that those who conducted 
research previously found conducting human subject research without IRB approval 
acceptable (Q1), while it was also statistically significant that making up of research data was 
found acceptable by those who did not conduct research. In some instances, those who 
conducted research were more accepting of unethical practices (e.g. dropping outliers without 
mentioning it was accepted by 62.5% of the responders who previously conducted scientific 
research) and in other instances it was the other way around (Figure 4) 
 
 
Prior ethics training effect on accepting misconduct: Correlation to prior ethics training as 
well could not confirm if the prior training of the participants had an effect on their views 
regarding acceptance of unethical practices, the percentages of participants who find 
unethical practices acceptable or very acceptable were close in those who received training 
on research ethics and those who did not. However, particularly in the questions related to 
plagiarism the results were much higher in those who have received trainings however this 
was not statistically significant (Figure 5) This could possibly relate to inefficiency of the 
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training, misconceptions not addressed by such training or other factors influencing the 
acceptance of those responders to unethical practices despite being trained. 
 
 
 
Gender effect on engaging in research misconduct or accepting it: Comparing 
percentages among males and females in regard to self reporting shows no significant 
differences (Table 20), on the other hand, percentages of males showing acceptance to 
unethical behavior, is generally higher than females, yet, this was only statistically significant 
for the use of confidential information about research subjects without their authorization. 
(Table 21) 
 
 
Research Environment effect on acceptance of unethical behavior: Those who indicated 
acceptability of unethical practices  without observing colleagues engage misconduct were 
found to be the lowest, with a highest percentage 11.6% for those who found giving 
authorship credit to someone who has not contributed substantively to a manuscript 
acceptable or very acceptable. In some instances however the percentages of those who never 
observed a misconduct and find it acceptable were higher than those who observed it at least 
once, such an example include not obtaining proper informed consent which is something 
that will not usually be openly observed. Another example is changing research data without 
mentioning it which is also something that will not be openly observed. Most of these 
correlations were statistically significant. 
 
 
Research Environment effect on engagement in unethical behavior: The comparison 
suggests a significant correlation between observing colleagues doing misconduct and 
engaging in misconduct. This correlation is evident as the highest self reported rate of 
misconduct that the reporters confirmed never observing a colleague do it was 5.3% for 
dropping outlier without mentioning it. Participants who never did misconduct yet observed it 
were as well consistently less than those who never observed it among their colleagues. For 
example making up of research data, was not committed by 56.3% of those who observed it, 
as compared to 96.3% to those who never observed it. Most of these correlations were 
statistically significant. 
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THE CASE OF BIOTECHNOLOGY RESEARCH 
 
In AUC’s Biotechnology Department, several different types of research are being 
performed.  Our results have strong implications for the ethical conduct of all of these types 
of researches. 
For example, researches that involve the obtainment of human biological samples, such as 
blood and urine, are commonly performed.   Our data showing the prevalence of different 
types of research misconducts either observed or self reported have the following relevance:  
 Breach of confidentiality of participants’ data: Such breaches can lead to adverse 
social consequences, including stigma and discriminatory actions, such as inability to 
gain employment and health insurance.  For example, inappropriate release of 
information related to a participants’ hepatitis C virus or HIV status could affect their 
employability, insurance eligibility and their social engagement.  These effects are 
also more likely to occur when the data involve genetic information. 
 Lack of protection of research participants: An important function of an institutional 
review board (IRB) is to ensure that research does not contain unnecessary risks. The 
IRB also identifies other risks that might not be appreciated by the investigators.  As a 
significant proportion of our sample size thought it was proper not to obtain IRB 
review, the lack of such review can result in undue risks to research subjects.  
 Potential research participants might not be adequately informed regarding important 
aspects of the research: Such lack of information could also be a consequence of not 
obtaining  IRB review and approval, since a function of the IRB is to ensure that 
consent forms contain the necessary basic elements of information needed for 
potential research participants to make a decision regarding their participation in the 
research.   IRBs also review the process of informed consent to certify that the 
consenting process is done in such a manner that ensures that consent is give 
voluntarily and does not involve coercion. Lack of a proper consent process can 
eventually lead to participants not being aware of their rights (e.g., not knowing their 
rights to decline or withdraw at any point of time).   
 
Obtaining an IRB approval is a corner stone in ensuring the rights and welfare of human 
research subjects.   The IRB acts as an independent body that adequately weighs risks and 
benefits, ensures risks are minimized, assesses conflicts of interests, reviews recruitment 
methods, responds to allegations and complaints of misconducts. Due to these important 
review functions of IRBs, our  survey study indicating that the conduct of human subject 
research without IRB approval, as self reported by more than 10% of the participants and 
observed at least once by more than 21%, warrants immediate attention. 
 
Other types of research at AUC include laboratory researches that involve bacterial and plant 
samples, all of which require best practices in the analysis and reporting of results obtained in 
these researchers.   
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However, fabrication and falsification of results can occur in any of the above mentioned 
types of biotechnology results.  As such, an aspect that was of significant concern in our 
study involving investigators at the AUC was the extent of reported incidence of fabrication 
and falsification, which was self reported by 26%, and observed by nearly 47% of the 
participants. Such misconducts could be a result of conflicting interests such as: 
 Pressure to maintain grant/funding: because biotechnology is a quickly 
developing field that occurs amidst much competition for funding. 
 Presence of potential commercial rewards: by selling the findings, starting a 
spinoff company or patenting inventions, most biotechnological findings can have 
great commercial value. 
 Pressure to publish/get promoted or even graduate.  
 
Biotechnology research might also involve the use of animals.  It is worth mentioning that at 
the AUC, ethical review of research involving animals is not currently being performed, as an 
animal research ethics committee does not exist.   Such animal research ethics committees 
ensure that the welfare of animals used in research are maintained. While Animal Rights 
principles are against using animals as experimental subjects, regulations describes what is 
known as Animal Welfare as a method to ensure animals are not cruelly abused. The federal 
law that regulates animal welfare is known as Animal Welfare Act, with the objective of 
minimizing the discomfort, pain and distress to the animals.  It sets basic rules for feeding, 
housing, handling, veterinary care, and even psychological well-being (CFR, n.d.). Our 
results indicate the ignoring aspects of animal subject requirement were observed at least 
once by 17.7 %of the participants, and not abiding to biosafety regulation by more than 34%.  
 
Regardless of one’s reasons to engage in such misconduct, the consequences have been 
shown to be quite severe in previous biotechnology studies.  I would like to review two such 
studies that demonstrate the severity of adverse outcomes stemming from research 
misconduct.   
One case involved that of Jesse Gelsinger, who died at the age of 18 as a result of his 
participation in a gene therapy clinical trial in 1999.  The trial testing for a new treatment for 
a genetic liver disease known as ornithine transcarbamase deficiency; This genetic disorder 
was due to a lack of the gene that encodes for ornithine transcarbamase. The trial was 
investigating the introduction of  a functional copy of the gene in participants by means of an 
adenovirus vector. Being a phase I trial, it was the first in human trial and it had no benefits 
anticipated for the participants. The maximum tolerable dose of the adenovirus vector was 
given to Gelsinger that caused a severe immune reaction leading to multiple organ failure and 
his death a few days later. (Shamoo and Resnik, 2009)   
There was several ethics violation in this trial.   For example, Jesse Gelsinger was not 
properly informed about the risks that he would be exposed to by participating in the study. 
This included the effects of the intervention on liver function, as adverse events that occurred 
in pre-clinical animal trials and in human subjects who had been enrolled prior to Jesse’s 
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participation were not properly reported to the FDA.   There were also issues with conflict of 
interests, as the principal investigator of the trial had ownership rights in the institute that 
would market any commercial tests that would result from the study.   
Another infamous scandal that combines conflict of interest, fabrication, and falsification was 
that of Duke University, in North Carolina.  In pre-clinical research, Dr. Annil Potti had  
fabricated and falsified results of a cancer treatment method that depended on genomic 
matching of patient’s DNA to the most suitable treatment.  Subsequently, a large clinical trial 
was conducted involving hundreds of patients who were led to believe that they might receive 
clinical benefit from their participation. A company was started with the “discovery” and 
more patients became involved, and due to the continued falsification and manipulation of the 
data, patients were not receiving the best treatments for their cancers as promised.. The 
university itself was accused of continuing to support the fraudulent research to make money 
(Deception at Duke, n.d.).  In January 2015, The Cancer Letter published a report indicating 
that a whistleblower has been asked to remain quiet by Duke University’s professors and 
deans. The University eventually settled all lawsuits related to Potti’s research for 
undisclosed terms. A number of Potti’s publications have been retracted. 
While biotechnological research at AUC may not involve treating patients and may not carry 
risks with extreme outcomes such as death, the same tools of bioinformatics, genomics, 
transcriptomics are being used in research done in the AUC.   As such, misconducts 
involving falsification, fabrication and conflicts of interest that occurred in the Gelsinger and 
the Duke studies can also occur at the AUC. Similar pressures to keep grants, get promoted, 
graduate or publish exists. Publishing of fraudulent results that are not of direct application at 
the moment may not be of direct harm to anyone, but such published results present 
opportunities to generate new results that can be misleading and eventually be harmful.  
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CONCLUSION 
 
The prevalence of misconduct observed was higher than self reported prevalence. Variations 
in the amount of misconduct were observed in different categories, the lowest related to 
conflict of interest and the highest related to falsification and fabrication. In self reported 
misconducts, the highest was in a question related to research practices and the lowest in 
question related to conflict of interest. 
 
In regards to attitudes, participants ranging from 3.6% to 10.7% found unethical 
misconducts acceptable or very acceptable. The majority of responders generally chose the 
“responsible conduct” responses in the study cases, choices that were not correct were more 
inclined towards less extreme unethical decisions. Responses were generally positive in 
regards to reporting of misconduct, monitoring of trainees and declaration of conflict of 
interest. However, the majority expressed concerns over amount of misconduct and indicated 
the commonality of dishonesty and misinterpretation of data. 
 
 Cross tabulating results showed significant correlations highest degree with 
the acceptability of misconduct, showing that the higher the scientific grade the lower is the 
acceptability of misconduct. It also suggested significant effect of the research environment 
on the acceptability of misconduct and the incidence of engaging in it. Correlation to research 
experience and training could not be established but the correlation suggested that trainings 
could possibly be not effective.   
 
  
LIMITATIONS 
This study included self-reporting of self-identified practices, which could represent an 
underestimate of actual practice. Individuals who committed misconduct may be reluctant to 
admit it even though the survey is anonymized and they cannot be identified, additionally 
people participants might as well be reluctant to report others or admit to own gaps. Also, 
results from a single university may not be generalizable to other universities in Egypt. 
 
NEXT STEPS 
Further data using the same survey is being collected from other institutes in Egypt and the 
Middle-East particularly from Bahrain and Lebanon and will be pooled to results from AUC 
to get a broader image.  
It is also recommended that further qualitative research (e.g., interview studies) is needed to 
explore further the possible reasons for the correlations identified.  
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CONCLUDING REMARKS 
 
Even thought different misconducts in different research fields can have different impact on 
people, and the amount of harm (or possibly no harm) can vary widely, misconduct remains 
an abuse against the science and the scientific method that we trust. Advances in science is 
primarily based on data assumed correct, where one builds on it, cite it and use it as building 
base to new concepts and to advance current applications. Falsified or fabricated data serve as 
an imaginary base that nothing can be based on, and building on it would consequently lead 
to waste of time and resources on top of possibility of harming research subjects or at the 
very least affecting the career of researchers depending on peers previous work. Accordingly, 
research misconduct should be taken very seriously, simply retracting and refunding of grants 
serve as a corrective action to a wrong situation, but it is not enough of a preventative action, 
civil and criminal liability based on the harm and even potential harm from such misconduct 
would be an example that would make anyone think twice before recklessly attempting 
misconduct. 
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Tables 
Table 1: Demographics of participants 
Gender Males  
Females 
31.9% 
66.5% 
Nationality Egyptian 
Non-Egyptian 
91.1% 
8.9% 
Position Undergraduate student 
MSc student 
PhD Student 
Research Position 
Academic position 
18.8% 
34.0% 
12.6% 
8.4% 
9.4% 
 
Received Ethics 
Training? 
If yes, training included 
research misconduct? 
No 
Yes      
                         Yes  
                         No 
                         Not sure/cannot remember 
43.5% 
52.4% 
        56.0% 
        11.0% 
         33.0% 
 Table 2: response rates to different types of questions. 
Total: 
 
Response rate percentage 
Initiated survey 
 
191/191 100 
Completed survey 
 
95/191 49.7 
Responders to questions about 
acceptance of misconduct 
 
112/191 58.6 
Responders to questions about 
prevalence of misconduct 
 
130/191 68.1 
Responders to questions about self-
reporting of misconduct 
114/191 59.7 
Responders to questions about                
self-reporting of misconduct 
who conducted research 
           77/114                 
67.5  
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Table 3: Acceptability of participants to misconducts related to Research Ethics 
 Very 
acceptable 
% 
Acceptable 
% 
 Neutral 
% 
 
Unacceptable 
% 
Definitely 
unacceptable 
% 
Conducting research 
involving human subjects 
without prior approval from 
an Institutional Review 
Board or Ethics Committee 
8 2.7 8.9 25 55.4 
Use of confidential 
information about research 
subjects without their 
authorisation 
5.4 1.8 5.4 9.8 77.7 
Not obtaining proper 
informed consent from 
participants 
5.4 0.9 10.7 24.1 58.9 
 
 
Table 4: Comparison between self reporting and observed misconduct in Research Ethics. 
 
 
Questions 
Observed Self reported 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
Conducting 
research 
involving 
human subjects 
without prior 
approval from 
an Institutional 
Review 
Board or Ethics 
Committee 
130 (68.1) 78.5 15.4 6.2 77 (67.5) 89.6 7.8 2.6 
Use of 
confidential 
information 
about research 
subjects 
without their 
authorisation 
130 (68.1) 80 15.4 4.6 77 (67.5) 93.5 6.5 0 
Not obtaining 
proper 
informed 
consent from 
participants 
130 (68.1) 65.4 22.3 12.3 77 (67.5) 89.6 7.8 2.6 
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 Table 5: Acceptability of Falsification and Fabrication (n=112) 
   
%Very 
acceptable  
%acceptable  % 
Neutral  
% 
unacceptable 
%Definitely 
unacceptable 
Making up 
research data 
5.4 4.5 1.8 13.4 75 
Changing 
research data 
without 
mentioning it. 
2.7 2.7 5.4 22.3 67 
Dropping 
“outliers” 
without 
mentioning it 
3.6 3.6 9.8 33.0 50.0 
Selecting only 
those data 
that support your 
hypothesis 
5.4 3.6 19.6 24.1 47.3 
 
Table 6: Comparison between self reporting and observed misconduct related to Falsification and Fabrication. 
 
 
Questions 
Observed Self reported 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
Making up 
research data 
  
130 (68.1) 65.4 29.2 5.4 77 (67.5) 88.3 11.7 0 
Changing 
research data 
without 
mentioning it. 
  
130 (68.1) 69.2 24.6 6.2 77 (67.5) 90.9 9.1 0 
Dropping 
“outliers” 
without 
mentioning it 
  
130 (68.1) 63.8 26.9 9.2 77 (67.5) 81.8 18.2 0 
Selecting only 
those data 
that support 
your hypothesis 
130 (68.1) 53.1 35.4 11.5 77 (67.5) 74.0 22.1 3.9 
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Table 7: Acceptability of  Plagiarism (n=112) 
Plagiarism   
%Very 
acceptable  
%acceptable  % 
Neutral  
% 
unacceptable 
%Definitely 
unacceptable 
Publishing 
results that 
belong to 
someone else 
4.5 0 0 8.9 86.6 
Using someone 
else’s words 
or ideas without 
giving 
proper credit 
3.6 1.8 0 22.3 72.3 
Submitting a 
manuscript to 
a journal that 
you already 
published in 
another 
Journal 
4.5 1.8 5.4 20.5 67.9 
  
 
Table 8: Comparison between self reporting and observed misconduct related to Plagiarism 
 
 
Questions 
Observed Self reported 
n 
(respons
e rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
Publishing results 
that 
belong to 
someone else 
130 
(68.1) 
73.1 19.2 7.7 77 (67.5) 92.2 6.5 1.3 
Using someone 
else’s words 
or ideas without 
giving proper 
credit 
130 
(68.1) 
56.2 35.4 8.5 77 (67.5) 90.9 7.8 1.3 
Submitting a 
manuscript to 
a journal that you 
already published 
in another 
Journal 
130 
(68.1) 
83.8 13.1 3.1 77 (67.5) 94.8 3.9 1.3 
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 Table 9: Acceptability of  misconducts related to Authorship (n=112) 
Authorship   
%Very 
acceptable  
%acceptable  % 
Neutral  
% 
unacceptable 
%Definitely 
unacceptable 
Giving authorship 
credit to someone 
who has not 
contributed 
substantively to 
a manuscript 
3.6 4.5 4.5 36.6 50.9 
Denying 
authorship credit 
to someone who 
has contributed 
substantively to 
a manuscript 
4.5 0 0.9 14.3 80.4 
Allowing your 
name to be 
put on papers to 
which you 
have made no 
reasonable 
contribution 
2.7 4.5 4.5 24.1 64.3 
 
Table 10: Comparison between self reporting and observed misconduct related to Authorship 
 
 
Questions 
Observed Self reported 
n 
(response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
Giving 
authorship credit 
to someone who 
has not 
contributed 
substantively to 
a manuscript 
130 
(68.1) 
62.3 23.8 13.8 77 (67.5) 85.7 10.4 3.9 
Denying 
authorship credit 
to someone who 
has contributed 
substantively to 
a manuscript 
130 
(68.1) 
75.4 20.0 4.6 77 (67.5) 94.8 3.9 1.3 
Allowing your 
name to be 
put on papers to 
which you 
have made no 
reasonable 
contribution 
NA NA NA NA 77 (67.5) 90.9 7.8 1.3 
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Table 11: Acceptability of misconduct related to Conflict of Interest (n=112) 
CONFLICT OF 
INTEREST 
  
%Very 
acceptable  
%acceptable  % Neutral  % 
unacceptable 
%Definitely 
unacceptable 
Aware of a conflict of 
interest (e.g. you have 
a financial interest 
with a drug company 
and you are 
conducting a study 
for them) and did not 
discloseit to either the 
ethics committee or a 
journal 
2.7 1.8 8.0 28.6 58.9 
Compromising the 
rigor of a study's 
design or 
methodology in 
response to 
pressure from a 
commercial or not-
for-profit funding 
source 
2.7 0.9 8.0 27.7 60.7 
Inappropriately 
altering or 
suppressing research 
results 
in response to 
pressure from 
a commercial or not-
for-profit 
funding source 
2.7 0.9 8.0 21.4 67.0 
 
 
 
 
 
 
 
 
 
 
 
49 
 
Table 12: Comparison between self reporting and observed misconduct related to Conflict of Interest 
 
 
Questions 
Observed Self reported 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
n (response 
rate%) 
Never 
% 
Once or 
twice % 
Three 
times or 
more % 
Aware of a 
conflict of 
interest  
and did not 
disclose 
it to either the 
ethics 
committee or a 
journal 
130 (68.1) 86.9 12.3 0.8 77 (67.5) 94.8 5.2 0 
Compromising 
the rigor of a 
study's design 
or 
methodology in 
response to 
pressure from a 
commercial 
or not-for-profit 
funding 
source 
130 (68.1) 86.9 11.5 1.5 77 (67.5) 96.1 3.9 0 
Inappropriately 
altering or 
suppressing 
research results 
in response to 
pressure from 
a commercial 
or not-for-profit 
funding source 
130 (68.1) 89.2 10.0 0.8 77 (67.5) 96.1 3.9 0 
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Table 13: Comparison between self reporting and observed misconduct related to Research Practices 
 
 
Questions 
Observed Self reported 
n 
(respons
e rate%) 
Nev
er % 
Once 
or 
twice 
% 
Three 
times or 
more % 
n 
(respons
e rate%) 
Never 
% 
Once 
or 
twice 
% 
Three 
times or 
more % 
Ignoring aspects of 
animal-subjects 
research requirements 
such as care, feeding, 
monitoring, 
130 
(68.1) 
82.3 12.3 5.4 77 (67.5) 90.9 6.5 2.6 
Ignoring aspects of 
materials-handling 
research requirements 
such as biosafety, 
radioactive materials, 
130 
(68.1) 
65.4 23.8 10.8 77 (67.5) 72.7 18.2 9.1 
Providing an 
inappropriately negative 
or positive letter of 
recommendation 
130 
(68.1) 
76.9 19.2 3.8 77 (67.5) 93.5 6.5 0 
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 Table 14: Attitudes of participants towards misconduct (n=110) 
Statement Strongly 
agree % 
Agree 
% 
Neutral 
% 
Disagree 
% 
Strongly 
disagree % 
I am concerned about the amount of 
misconduct that occurs 
30 47.3 16.4 5.5 0.9 
The responsibility of misconduct lies with 
the principal investigator only  
10 12.7 10.9 48.2 18.2 
Dishonesty and misrepresentation of data 
are common 
15.5 34.5 25.5 13.6 10.9 
Investigators should report instances of 
research misconduct 
44.5 40.9 9.1 3.6 1.8 
There are appropriate mechanisms in place 
to report misconduct at my institution 
20.9 24.5 32.7 16.4 5.5 
The pressures to publish studies to gain 
promotion is a major reason why 
investigators engage in research 
misconduct. 
22.7 41.8 19.1 13.6 2.7 
Investigators should declare conflicts of 
interest to the appropriate officials 
42.7 42.7 12.7 0.9 0.9 
I monitor my trainees' work to ensure that 
they are developing into responsible 
researchers 
36.4 30.9 30.9 1.8 0 
I am aware of regulations that govern 
research involving humans, animals, or 
laboratory practices. 
31.8 40.0 17.3 10.9 0 
 
Table 15: Responses rates to different answer choices for Case 1 
Case 1- You have received a manuscript for review from a journal editor. You believe the 
paper is very good and realize that it contains a new insight that is relevant to the content 
of a paper you are currently writing. Which of the following actions is most appropriate? 
A. Tell the journal editor that the paper you reviewed should not be published.  8.4% 
B. Implement the ideas in your own paper and quickly prepare to submit it for review. 
When your own paper has been submitted, return the manuscript to the editor with 
the comment that you cannot review it because of a conflict of interest.  
13.7% 
C. Promptly write a conscientious review, but delay implementing the ideas that would 
facilitate your own research until the reviewed paper has been published.  
71.6% 
D. Implement the ideas in your own paper and quickly prepare to submit it for review. 
Delay returning your favorable review of the journal's manuscript until your own 
paper has been submitted.  
6.3% 
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Table 16: Responses rates to different answer choices for Case 2 
Case 2- You are performing a study on the side effects of a newly approved drug, Restex, compared to other sleep 
aids drugs that are currently approved. The company who makes 
Restex finds out about the study and offers to provide you with financial support to 
complete the study more quickly. The company will pay you $200 per participant recruited 
into the study; it will also pay for the Restex drug, key personnel working on your study, 
and any study related procedures required to evaluate the drug’s effectiveness. In  
exchange, the company wants to have access to the data and to your paper before you 
publish. What action would you take? 
A- Don’t agree to the company’s proposal.  51.6% 
B- Agree to the company’s proposal but do not disclose the agreement to the Research Ethics 
Committee.  
2.1% 
C- Agree to the company’s proposal and disclose the information to the Research Ethics 
Committee. 
46.3% 
D- Agree to the company’s proposal and give them false data in return.   0% 
  
Table 17: Responses rates to different answer choices for Case 3 
Case 3- Dr. Ahmed and her graduate student, Samer, are working together on a study about 
alternative therapies for fever. Dr. Ahmed is unwilling to share her entire dataset with 
colleagues before publishing her interpretation of the data. Samer, however, has access to 
the database as part of his current project and decides that it is ethical for him to look 
more closely at the data. Samer realizes that Dr. Ahmed has excluded specific data points 
that impact her interpretation. Samer realizes that if he includes these data points, an 
entirely new understanding of therapies to treat fever will emerge. What should Samer do? 
A- Do nothing since Dr. Ahmed is his superior 3.2% 
B- Write a separate paper on his findings 5.3% 
C- Immediately report Dr. Ahmed to the Research Ethics Committee 16.8% 
D- Talk to Dr. Ahmed about his findings 74.7% 
 
 
Table 18: Responses rates to different answer choices for Case 4 
Case 4- Mohamed is in the final stage of his dissertation work involving a survey study. 
While performing his statistical analysis, he realizes that none of his results are statistically 
significant. He thinks that if he had a larger sample size (about 20 more samples) his 
results would gain significance, but it is too late to recruit more participants and he needs 
to get his final draft to his advisor by the end of the week in time to finish his PhD 
requirements. What should Mohamed do? 
A- Duplicate some of the sample responses to gain significance 6.3% 
B- Report his findings as is 82.1% 
C- Find twenty friends to complete the survey although they would not meet study inclusion 
criteria. 
3.2% 
D- Report the p values as being significant (i.e., p<0.05) 8.4% 
  
 
Table 19: Responses rates to different answer choices for Case 5 
Case 5- Your paper was published in a premiere international medical journal, but one of 
your students has noticed that several paragraphs in your paper contain sections that 
were copied word for word directly from another publication without referencing this other 
publication. What should you do? 
A- Call the editor to withdraw the paper 76.8% 
B- Tell the student that it is too late to withdraw the paper 5.3% 
C- Call the author of the other paper to apologize 13.7% 
D- Wait and see if anyone else notices the copied material 4.2% 
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Table 20: Rates of self reporting and  gender 
Questions Never % Once or twice 
% 
Three or more 
times % 
M F M F M F 
Research Ethics       
Conducting research involving human subjects without 
prior approval from an Institutional Review Board or 
Ethics Committee 
95.5 87 0 11.1 4.5 1.1 
Use of confidential information about research subjects 
without their authorisation 
95.5 92.6 4.5 7.4 0 0 
Not obtaining proper informed consent from participants 86.4 90.7 9.1 7.4 4.5 1.9 
Fabrication and Falsification       
Making up research data 81.8 90.7 18.2 9.3 0 0 
Changing research data without mentioning it. 90.9 90.7 9.1 9.3 0 0 
Dropping “outliers” without mentioning it 81.8 81.5 18.2 18.5 0 0 
Selecting only those data that support your hypothesis 72.7 74.1 22.7 22.2 4.5 3.7 
Plagiarism       
Publishing results that belong to someone else 90.9 92.6 9.1 5.6 0 1.9 
Using someone else’s words or ideas without giving 
proper credit 
90.9 90.7 9.1 7.4 0 1.9 
Submitting a manuscript to a journal that you already 
published in another Journal 
100 92.6 0 5.6 0 1.9 
Authorship       
Giving authorship credit to someone who has not 
contributed substantively to a manuscript 
90.9 83.3 4.5 13 4.5 3.7 
Denying authorship credit to someone who has 
contributed substantively to a manuscript 
100 92.6 0 5.6 0 1.9 
Allowing your name to be put on papers to which you 
made no reasonable contribution 
100 87 0 11.1 0 1.9 
Conflict of Interest       
Aware of a conflict of interest (e.g. you have a financial 
interest with a drug company and you are conducting a 
study for them) and did not disclose it to either the ethics 
committee or a journal 
95.5 94.4 4.5 4.6 0 0 
Compromising the rigor of a study's design or 
methodology in response to pressure from a commercial 
or not-for-profit funding source 
100 94.4 0 5.6 0 0 
Inappropriately altering or suppressing research results 
in response to pressure from a commercial or not-for-
profit funding source 
100 94.4 0 5.6 0 0 
 
(Males=22, Females=54, no response =1, Total=77) 
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Table 21: Rates of acceptance of misconduct and gender 
Questions Acceptable % Neutral % Not Acceptable 
% 
M F M F M F 
Research Ethics       
Conducting research involving human subjects without 
prior approval from an Institutional Review Board or 
Ethics Committee 
91.0 11.5 9.1 7.7 81.8 80.7 
Use of confidential information about research subjects 
without their authorisation* 
12.1 5.1 6.1 3.8 81.8 91 
Not obtaining proper informed consent from participants 9.1 51.4 9.1 11.5 81.8 83.3 
Fabrication and Falsification       
Making up research data 12.2 8.9 3 1.3 84.9 89.7 
Changing research data without mentioning it. 9.1 3.9 9.1 3.8 81.8 92.3 
Dropping “outliers” without mentioning it 15.2 3.9 18.2 6.4 66.7 89.8 
Selecting only those data that support your hypothesis 12.2 7.7 18.2 20.5 69.7 71.8 
Plagiarism       
Publishing results that belong to someone else 6.1 3.8 0 0 94 96.1 
Using someone else’s words or ideas without giving 
proper credit 
9.1 3.8 0 0 90.9 96.1 
Submitting a manuscript to a journal that you already 
published in another Journal 
9.1 5.1 3 6.4 87.9 88.4 
Authorship       
Giving authorship credit to someone who has not 
contributed substantively to a manuscript 
12.1 6.4 3 5.1 84.8 88.4 
Denying authorship credit to someone who has 
contributed substantively to a manuscript 
6.1 3.8 3 0 90.9 96.1 
Allowing your name to be put on papers to which you 
made no reasonable contribution 
9.1 6.4 6.1 3.8 84.9 89.8 
Conflict of Interest       
Aware of a conflict of interest (e.g. you have a financial 
interest with a drug company and you are conducting a 
study for them) and did not disclose it to either the ethics 
committee or a journal 
6 3.9 6.1 9 87.9 87.1 
Compromising the rigor of a study's design or 
methodology in response to pressure from a commercial 
or not-for-profit funding source 
6 2.6 9.1 7.7 84.9 89.8 
Inappropriately altering or suppressing research results 
in response to pressure from a commercial or not-for-
profit funding source 
6 2.6 3 10.3 90.9 87.2 
 
(*p<0.05, Males=33, Females=78, no response=1, Total=112)
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*6. Current position: 
 
mlj 
 
Undergraduate 
 
mlj MSc student 
 
mlj PhD student 
 
mlj Postdoctoral 
 
mlj Assistant Professor (or equivalent) 
 
mlj Associate Professor (or equivalent) 
 
mlj Full Professor (or equivalent) 
 
mlj Emeritus Professor 
 
mlj Technician 
 
mlj Research Assistant 
 
mlj Lecturer 
 
mlj Other (please specify) 
 
 
 
*7. Have you ever conducted a scientific research study including in your 
thesis? 
 
mlj 
 
Yes 
 
mlj    No 
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8. What type(s) of research were you involved in (check all that apply)? 
 
fec Human subject research (e.g. clinical trials or survey studies) 
 
fec Experimental animals 
 
fec Human biological samples 
 
fec Laboratory research 
 
fec Other (please specify) 
 
 
 
*9. Have you had prior ethics training? 
 
mlj 
 
Yes 
 
mlj    No 
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10. Did this training include education in research misconduct? 
 
C'   Yes 
 
("'     No 
 
("'     Not sure I Cannot  remember 
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PREVALENCE OF SCIENTIFIC MISCONDUCT - YOUR COLLEAGUES 
 
 
Within the last three years, have you observed or had other direct evidence of any of your COLLEAGUES engaging in 
any of the below behaviors within the last 3 years? Please indicate the frequency. 
 
*11. RESEARCH ETHICS 
 
 
Conducting research 
involving human subjects 
without prior approval from 
an Institutional Review 
Board or Ethics Committee 
Use of confidential 
information about research 
subjects without their 
authorisation 
Not obtaining proper 
informed consent from 
participants 
Never Once or twice Three or more 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
mlj mlj mlj 
 
 
 
 
nmlkj nmlkj nmlkj 
 
*12. DATA FABRICATION & FALSIFICATION 
Never Once or twice Three or more 
 
Making up research data nmlkj nmlkj nmlkj 
 
Changing research data 
without mentioning it. 
Dropping “outliers” without 
mentioning it 
Selecting only those data 
that support your 
hypothesis 
 
*13. PLAGIARISM 
 
 
Publishing results that 
belong to someone else 
Using someone else’s words 
or ideas without giving 
proper credit 
Submitting a manuscript 
that has already been 
published in another 
journal 
 
mlj                                                             mlj                                                             mlj 
nmlkj                                                             nmlkj                                                             nmlkj 
mlj                                                             mlj                                                             mlj 
 
 
 
 
Never Once or twice Three or more 
 
nmlkj                                                             nmlkj                                                             nmlkj 
mlj                                                             mlj                                                             mlj 
 
nmlkj                                                             nmlkj                                                             nmlkj 
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*14. AUTHORSHIP 
 
 
Giving authorship credit to 
someone who has not 
contributed substantively to 
a manuscript 
Denying authorship credit 
to someone who has 
contributed substantively to 
a manuscript 
 
 
 
Never Once or twice Three or more 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
*15. CONFLICT OF INTEREST 
Never Once or twice Three or 
more 
 
Having a conflict of interest 
(e.g. a person had a 
financial interest with a 
drug company and were 
conducting a study for the 
company) and not 
disclosing it to either the 
ethics committee or a 
journal 
Compromising the rigor of 
a study's design or 
methodology in response 
to pressure from a 
commercial or not-for-profit 
funding source 
Inappropriately altering or 
suppressing research results 
in response to pressure 
from a commercial or not- 
for-profit funding source 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
 
 
 
 
 
mlj mlj mlj 
 
 
 
 
 
 
 
nmlkj nmlkj nmlkj 
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*16. RESEARCH PRACTICES 
Never Once or twice Three or more 
 
Ignoring aspects of animal- 
subjects research 
requirements such as care, 
feeding, monitoring, etc. 
Ignoring aspects of 
materials-handling 
research requirements such 
as biosafety, radioactive 
materials, etc. 
Providing an 
inappropriately negative or 
positive letter of 
recommendation 
Inadequate record keeping 
related to research 
proposals 
Cutting corners because 
one was in a hurry to 
complete a project 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
 
 
 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
 
 
nmlkj nmlkj nmlkj 
 
17. Were any of the question on this page difficult or confusing to understand? If so, 
which 
questions? 
 
5 
 
6 
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PREVALENCE OF SCIENTIFIC MISCONDUCT - YOURSELF 
 
 
Please tell us how many times YOU have engaged in any of these behaviors within the last three years. 
 
*18. RESEARCH PRACTICES 
Never Once or twice Three or 
more 
 
Ignoring aspects of animal- 
subjects research 
requirements such as care, 
feeding, monitoring, etc. 
Ignoring aspects of 
materials-handling 
research requirements such 
as biosafety, radioactive 
materials, etc. 
Providing an 
inappropriately negative or 
positive letter of 
recommendation 
Inadequate record keeping 
related to research 
proposals 
Cutting corners because 
you were in a hurry in order 
to complete a project 
 
*19. RESEARCH ETHICS 
 
 
Conducting research 
involving human subjects 
without prior approval from 
an Institutional Review 
Board or Ethics Committee 
Use of confidential 
information about research 
subjects without their 
authorisation 
Not obtaining proper 
informed consent from 
participants 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
 
 
 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
Never Once or twice Three or more 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
mlj mlj mlj 
 
 
 
 
nmlkj nmlkj nmlkj 
 
*20. DATA FABRICATION & FALSIFICATION 
Never Once or twice Three or 
more 
 
Making up research data nmlkj nmlkj nmlkj 
 
Changing research data 
without mentioning it. 
Dropping “outliers” without 
mentioning it 
Selecting only those data 
that support your 
hypothesis 
 
mlj                                                             mlj                                                             mlj 
nmlkj                                                             nmlkj                                                             nmlkj 
mlj                                                             mlj                                                             mlj 
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*21. PLAGIARISM 
 
 
Publishing results that 
belong to someone else 
Using someone else’s words 
or ideas without giving 
proper credit 
Submitting a manuscript to 
a journal that you already 
published in another 
journal 
 
*22. AUTHORSHIP 
 
 
Giving authorship credit to 
someone who has not 
contributed substantively to 
a manuscript 
Denying authorship credit 
to someone who has 
contributed substantively to 
a manuscript 
Allowing your name to be 
put on papers to which you 
have made no reasonable 
contribution 
 
 
 
Never Once or twice Three or more 
 
nmlkj nmlkj nmlkj 
mlj mlj mlj 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
 
 
Never Once or twice Three or more 
 
nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj 
 
 
 
 
nmlkj nmlkj nmlkj 
 
*23. CONFLICT OF INTEREST 
Never Once or twice Three or more 
 
Aware of a conflict of 
interest (e.g. you have a 
financial interest with a 
drug company and you are 
conducting a study for 
them) and did not disclose 
it to either the ethics 
committee or a journal 
Compromising the rigor of 
a study's design or 
methodology in response 
to pressure from a 
commercial or not-for-profit 
funding source 
Inappropriately altering or 
suppressing research results 
in response to pressure 
from a commercial or not- 
for-profit funding source 
 
nmlkj nmlkj nmlkj 
 
 
 
 
 
 
 
 
 
mlj mlj mlj 
 
 
 
 
 
 
 
nmlkj nmlkj nmlkj 
 
24. Were any of the question on this page difficult or confusing to understand? If so, 
which 
questions? 
 
5 
 
6 
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ACCEPTABILITY OF PRACTICES IN CONDUCT OF RESEARCH 
 
 
Please rate the extent (on the below 5 point scale) to which you think any of the below behaviors are acceptable. 
 
*25. RESEARCH ETHICS 
 
Very Acceptable Acceptable Neutral Unacceptable 
Definitely 
Unacceptable 
 
Conducting research 
involving human subjects 
without prior approval from 
an Institutional Review 
Board or Ethics Committee 
Use of confidential 
information about research 
subjects without their 
authorisation 
Not obtaining proper 
informed consent from 
participants 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
 
 
 
 
mlj mlj mlj mlj mlj 
 
 
 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
*26. DATA FABRICATION & FALSIFICATION 
 
Very Acceptable Acceptable Neutral Unacceptable 
 
 
Definitely 
Unacceptable 
 
Making up research data nmlkj nmlkj nmlkj nmlkj nmlkj 
 
Changing research data 
without mentioning it. 
Dropping “outliers” without 
mentioning it 
Selecting only those data 
that support your hypothesis 
 
*27. PLAGIARISM 
 
mlj                                   mlj                                   mlj                                   mlj                                   mlj 
nmlkj                                   nmlkj                                   nmlkj                                   nmlkj                                   nmlkj 
mlj                                   mlj                                   mlj                                   mlj                                   mlj 
 
 
Definitely 
Very Acceptable Acceptable Neutral Unacceptable  
Unacceptable 
 
Publishing results that 
belong to someone else 
Using someone else’s words 
or ideas without giving 
proper credit 
Submitting a manuscript to 
a journal that you already 
published in another 
journal 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
mlj mlj mlj mlj mlj 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
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*28. AUTHORSHIP 
 
 
Very Acceptable Acceptable Neutral Unacceptable 
 
 
 
Definitely 
Unacceptable 
 
Giving authorship credit to 
someone who has not 
contributed substantively to 
a manuscript 
Denying authorship credit 
to someone who has 
contributed substantively to 
a manuscript 
Allowing your name to be 
put on papers to which you 
have made no reasonable 
contribution 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
 
 
 
mlj mlj mlj mlj mlj 
 
 
 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
*29. CONFLICT OF INTEREST 
 
Very Acceptable Acceptable Neutral Unacceptable 
 
 
Definitely 
Unacceptable 
 
Aware of a conflict of 
interest (e.g. you have a 
financial interest with a 
drug company and you are 
conducting a study for 
them) and did not disclose 
it to either the ethics 
committee or a journal 
Compromising the rigor of a 
study's design or 
methodology in response to 
pressure from a commercial 
or not-for-profit funding 
source 
Inappropriately altering or 
suppressing research results 
in response to pressure from 
a commercial or not-for- 
profit funding source 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
 
 
 
 
 
 
 
 
mlj mlj mlj mlj mlj 
 
 
 
 
 
 
 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
30. Were any of the question on this page difficult or confusing to understand? If so, 
which 
questions? 
 
5 
 
6 
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ATTITUDES OF SCIENTIFIC MISCONDUCT 
 
 
*31. Please indicate the extent of the degree with which you agree or disagree with 
the following statements 
 Strongly Agree Agree Neutral Disagree Strongly Disagree 
I’m concerned about the nmlkj nmlkj nmlkj nmlkj nmlkj 
amount of misconduct that      
occurs.      
The responsibility for mlj mlj mlj mlj mlj 
misconduct lies with the      
principal investigator only.      
Dishonesty and nmlkj nmlkj nmlkj nmlkj nmlkj 
misrepresentation of data      
are common      
Investigators should report mlj mlj mlj mlj mlj 
instances of research      
misconduct.      
There are appropriate nmlkj nmlkj nmlkj nmlkj nmlkj 
mechanisms in place to      
report misconduct at my      
institution      
The pressures to publish mlj mlj mlj mlj mlj 
studies to gain promotion is      
a major reason why      
investigators engage in      
research misconduct.      
Investigators should declare nmlkj nmlkj nmlkj nmlkj nmlkj 
conflicts of interest to the      
appropriate officials      
I monitor my trainees' work mlj mlj mlj mlj mlj 
to ensure that they are      
developing into responsible      
researchers      
I am aware of regulations nmlkj nmlkj nmlkj nmlkj nmlkj 
that govern research      
involving humans, animals,      
or laboratory practices.      
 
32. Were any of the question on this page difficult or confusing to understand? If so, 
which questions? 
 
5 
 
6 
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QUESTIONS ABOUT SCIENTIFIC MISCONDUCT 
 
*33. You have received a manuscript for review from a journal editor. You believe the 
paper is very good and realize that it contains a new insight that is relevant to the content 
of a paper you are currently writing. Which of the following actions is most 
appropriate? 
 
mlj 
 
Tell the journal editor that the paper you reviewed should not be published. 
 
mlj Implement the ideas in your own paper and quickly prepare to submit it for review. When your own paper has been submitted, return the 
 
manuscript to the editor with the comment that you cannot review it because of a conflict of interest. 
 
mlj Promptly write a conscientious review, but delay implementing the ideas that would facilitate your own research until the reviewed paper 
 
has been published. 
 
mlj Implement the ideas in your own paper and quickly prepare to submit it for review. Delay returning your favorable review of the journal's 
 
manuscript until your own paper has been submitted. 
 
*34. You are performing a study on the side effects of a newly-approved drug, Restex, 
compared to other sleep aids drugs that are currently approved. The company who 
makes Restex finds out about the study and offers to provide you with financial 
support to complete the study more quickly. The company will pay you $200 per 
participant recruited into the study; it will also pay for the Restex drug, key personnel 
working on your study, and any study-related procedures required to evaluate the 
drug’s effectiveness. In exchange, the company wants to have access to the data and 
to your paper before you publish. What action would you take? 
 
mlj 
 
Don’t agree to the company’s proposal 
 
mlj Agree to the company’s proposal but do not disclose the agreement to the Research Ethics Committee 
 
mlj Agree to the company’s proposal and disclose the information to the Research Ethics Committee 
 
mlj Agree to the company’s proposal and give them false data in return 
 
*35. Dr. Ahmed and her graduate student, Samer, are working together on a study 
about alternative therapies for fever. Dr. Ahmed is unwilling to share her entire dataset 
with colleagues before publishing her interpretation of the data. Samer, however, has 
access to the database as part of his current project and decides that it is ethical for him 
to look 
more closely at the data. Samer realizes that Dr. Ahmed has excluded specific data 
points that impact her interpretation. Samer realizes that if he includes these data 
points, an 
entirely new understanding of therapies to treat fever will emerge. What should Samer 
do? 
 
mlj Do nothing since Dr. Ahmed is his superior 
 
mlj Write a separate paper on his findings 
 
mlj Immediately report Dr. Ahmed to the Research Ethics Committee
lj Talk to Dr. Ahmed about his findings 
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*36. Mohamed is in the final stage of his dissertation work involving a survey study. 
While performing his statistical analysis, he realizes that none of his results are 
statistically 
significant. He thinks that if he had a larger sample size (about 20 more samples) his 
results would gain significance, but it is too late to recruit more participants and he 
needs to get his final draft to his advisor by the end of the week in time to finish his 
PhD requirements. What should Mohamed do? 
 
mlj 
 
Duplicate some of the sample responses to gain significance 
 
mlj Report his findings as is 
 
mlj Find twenty friends to complete the survey although they would not meet study inclusion criteria. 
 
mlj Report the p values as being significant (i.e., p<0.05) 
 
*37. Your paper was published in a premiere international medical journal, but one of 
your students has noticed that several paragraphs in your paper contain sections that 
were copied word for word directly from another publication without referencing this 
other publication. What should you do? 
 
mlj 
 
Call the editor to withdraw the paper 
 
mlj Tell the student that it is too late to withdraw the paper 
 
mlj Call the author of the other paper to apologize 
 
mlj Wait and see if anyone else notices the copied material 
 
 
38. Were any of the question on this page difficult or confusing to understand? If so, 
which 
questions? 
 
5 
 
6 
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ASSESSMENT OF THIS SURVEY 
 
 
*39. Assessment 
Please choose the best answer for each of the following statements. 
 
 Strongly Agree Agree Neutral Disagree Strongly Disagree 
The time to complete this 
survey was reasonable. 
nmlkj nmlkj nmlkj nmlkj nmlkj 
The instructions were easy 
to follow. 
mlj mlj mlj mlj mlj 
The questions were clear 
and understandable. 
nmlkj nmlkj nmlkj nmlkj nmlkj 
The questions on the survey 
were appropriate. 
mlj mlj mlj mlj mlj 
This survey will produce 
useful information. 
nmlkj nmlkj nmlkj nmlkj nmlkj 
 
*40. Please select the choice that best represents the time it took to complete this 
survey: 
 
mlj 
 
Less than 30 minutes 
 
mlj Between 30 and 60 minutes 
 
mlj Between 1 and 2 hours 
 
mlj Greater than 2 hours 
 
 
41. Which items on the survey are not important? 
 
5 
 
6 
 
42. What other items should be on the survey? 
 
5 
 
6 
 
43. Please add any additional comments 
 
5 
 
6
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Thank you for completing this survey! 
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Appendix II  
 
Dear Investigator: 
 
We are conducting a research survey involving researchers in several countries in the 
Middle East. The purpose of this survey is to know better the attitudes of researchers 
regarding their conduct in research. 
 
This survey will take approximately 30 minutes to complete. 
 
Further information and the survey can be accessed via the following link 
https://www.surveymonkey.com/s/rcregypt 
 
 
Your responses will be anonymous.  Data will never be reported in a way that 
identifies individuals. 
 
Your participation in this survey is completely voluntary. This survey has been 
reviewed by the research ethics committees at several institutions.  
 
If you include your contact information at the end of the survey, you will be included 
in a raffle to win one of three Apple iPad Minis. 
 
Thank you in advance for your participation.  
 
Regards,  
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Appendix III 
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Appendix IV 
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